Companies Attending the Summit

6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit 2024

Develop Robust Analytical Methods & Tools in a Phase-Appropriate & Cost-Efficient Manner, to Improve Cell Characterization, Expedite Product Release & Gain Regulatory Approval

Welcome to the 6th Cell Therapy Analytical Development Summit

Demonstrating your cell therapy’s superior safety and efficacy is vital for standing out in a competitive market and attracting investment. Integrating cutting-edge technologies and robust analytical methods is key to showcasing your product's strengths and securing regulatory approval.

Join the 6th Cell Therapy Analytical Development Summit to advance your analytics, accelerate through IND and clinical trials, and achieve regulatory success.

Explore three focused tracks on immunophenotype, cell-based, and molecular assays. Collaborate with industry leaders like Bristol Myers Squibb, Kite Pharma, and Takeda, and gain actionable insights to propel your pipeline forward. 

Engage with experts to overcome challenges in potency, product characterization, method validation, release, and scale-up.

Together, let’s elevate the development of potent, safe, and effective cell therapies.

6th Cell Therapy Analytical Development Summit Brochure
6th Cell Therapy Analytical Development Summit - Potency Topic
Download the Event Guide, 6th Cell Therapy Analytical Development Summit 2024
6th Cell Therapy Analytical Development Summit - Event Details

Our Expert Speaker Faculty:

Our Partners:

Lead

Miltenyi Biotec - Cell Therapy Analytical Development

Expertise

Agilent - Cell Therapy Analytical Development
Slingshot Biosciences Logo
ThermoFisher Scientific - Cell Therapy Analytical Development
BD Logo

Program

Accelix - Cell Therapy Analytical Development
Biomerieux - Cell Therapy Analytical Development
LumaCyte - Cell Therapy Analytical Development

Innovation

Axion - Cell Therapy Analytical Development
comprehensive cell solutions, Cell Therapy Analytical Development
stemcell science news (1)
Mission Bio - Cell Therapy Analytical Development
immudex

Exhibition

Intertek company logo
Qiagen Logo
Alliance for Regenerative Medicines- Cell Therapy Analytical Development

"This summit highlights the need for continued conversations on analytical assay design for cell therapies. In 2024, I look forward to discussing major changes ushered into CGT development via the novel platform technology designation and potency assurance.”
Manager, Science & Industry Affairs,
Alliance for Regenerative Medicine (2024 Speaker)

 

Alliance for Regenerative Medicines- Cell Therapy Analytical Development
Satellite Bio Logo

"With constantly evolving therapies and their regulations, it is important to have a space like this for the stakeholders to come together and share their knowledge and experiences.”
Senior Scientist, Process Development Drug Substance,
 Satellite Bio (2024 Speaker)

 

Satellite Bio Logo
Takeda Logo

"I have been a regular attendee at this conference and it's always been a spot to meet new cell therapy SMEs and reconnect with some others.”
Head of Analytical Development,
Takeda (2024 Speaker)

 

Takeda Logo
University of Minnesota Logo

"The 6th Cell Therapy Analytical Development Summit is a pivotal event for advancing the field of cell therapy. It provides an unparalleled platform for sharing cutting-edge research, fostering collaborations, and addressing the latest challenges in analytical development. I am eagerly looking forward to the 2024 meeting in Boston to engage with industry leaders and contribute to the discussions that will shape the future of cell therapy.”
Director, Quality Assurance & Regulatory Affairs, University of Minnesota (2024 Speaker)

 

University of Minnesota Logo
Merck Logo

"I enjoyed the well-organized conference and streamlined tracks of different focus. I learned what the key questions are that all are interested in and need to be addressed, which will guide us to better develop cell therapy drugs.”
Principal Scientist, Merck & Co. (Past Attendee)

 

Merck Logo
iXCells Biotechnologies Logo

"Cell therapy processes and assays are very complex. We are looking forward to hearing about new technologies and innovations in cell therapy development. We also would like to learn the regulatory perspective towards release assays.”
Vice President, Cell Therapy, Aisaer/IxCell Biotechnology (2024 Speaker)

 

iXCells Biotechnologies Logo